1. Home
  2. ZYME
  3. ZYME News

Latest Zymeworks Inc. (ZYME) News on May 10, 2025

Zymeworks Provides Corporate Update and Reports First Quarter 2025 Financial Results
ZYME

GlobeNewswire

2 days ago

Zymeworks Provides Corporate Update and Reports First Quarter 2025 Financial Results

Zymeworks Inc (ZYME) Q1 2025 Earnings Report Preview: What To Expect
ZYME

GuruFocus.com

3 days ago

Zymeworks Inc (ZYME) Q1 2025 Earnings Report Preview: What To Expect

Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting
ZYME

GlobeNewswire

15 days ago

Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting

Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development
ZYME

GlobeNewswire

19 days ago

Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development

Zymeworks to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025
ZYME

GlobeNewswire

23 days ago

Zymeworks to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025

Zymeworks Announces Participation in Upcoming Investor Conferences
ZYME

GlobeNewswire

a month ago

Zymeworks Announces Participation in Upcoming Investor Conferences

Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting
ZYME

GlobeNewswire

a month ago

Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting

Analysts Just Shipped A Captivating Upgrade To Their Zymeworks Inc. (NASDAQ:ZYME) Estimates
ZYME

Simply Wall St.

2 months ago

Analysts Just Shipped A Captivating Upgrade To Their Zymeworks Inc. (NASDAQ:ZYME) Estimates

Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
ZYME

GlobeNewswire

2 months ago

Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Zymeworks Inc (ZYME) Q4 2024 Earnings Report Preview: What To Look For
ZYME

GuruFocus.com

2 months ago

Zymeworks Inc (ZYME) Q4 2024 Earnings Report Preview: What To Look For

Zymeworks Announces Achievement of $14 Million Milestone from GSK Collaboration
ZYME

GlobeNewswire

2 months ago

Zymeworks Announces Achievement of $14 Million Milestone from GSK Collaboration

Zymeworks Announces Participation in Upcoming Investor Conferences
ZYME

GlobeNewswire

2 months ago

Zymeworks Announces Participation in Upcoming Investor Conferences

Zymeworks Announces Appointment of Oleg Nodelman to Board of Directors
ZYME

GlobeNewswire

3 months ago

Zymeworks Announces Appointment of Oleg Nodelman to Board of Directors

Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 5, 2025
ZYME

GlobeNewswire

3 months ago

Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 5, 2025

Zymeworks Announces Participation in Upcoming Investor Conferences
ZYME

GlobeNewswire

3 months ago

Zymeworks Announces Participation in Upcoming Investor Conferences

The past five years for Zymeworks (NASDAQ:ZYME) investors has not been profitable
ZYME

Simply Wall St.

4 months ago

The past five years for Zymeworks (NASDAQ:ZYME) investors has not been profitable

Zymeworks Outlines Strategic Priorities and Outlook for 2025 and 2026
ZYME

GlobeNewswire

4 months ago

Zymeworks Outlines Strategic Priorities and Outlook for 2025 and 2026

Zymeworks (NASDAQ:ZYME) Is In A Good Position To Deliver On Growth Plans
ZYME

Simply Wall St.

5 months ago

Zymeworks (NASDAQ:ZYME) Is In A Good Position To Deliver On Growth Plans

Zymeworks Hosts R&D Day Highlighting Continued Clinical Progress in Oncology Programs and Expansion into Autoimmune and Inflammatory Diseases
ZYME

GlobeNewswire

5 months ago

Zymeworks Hosts R&D Day Highlighting Continued Clinical Progress in Oncology Programs and Expansion into Autoimmune and Inflammatory Diseases

Zymeworks Announces Participation in Upcoming Investor Conferences
ZYME

GlobeNewswire

6 months ago

Zymeworks Announces Participation in Upcoming Investor Conferences

FDA Grants U.S. Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)
ZYME

GlobeNewswire

6 months ago

FDA Grants U.S. Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW191 in Folate Receptor-⍺ Expressing Advanced Solid Tumors
ZYME

GlobeNewswire

6 months ago

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW191 in Folate Receptor-⍺ Expressing Advanced Solid Tumors

Zymeworks Third Quarter 2024 Earnings: Revenues Disappoint
ZYME

Simply Wall St.

6 months ago

Zymeworks Third Quarter 2024 Earnings: Revenues Disappoint

Zymeworks Inc. (NASDAQ:ZYME) Analysts Are Reducing Their Forecasts For Next Year
ZYME

Simply Wall St.

6 months ago

Zymeworks Inc. (NASDAQ:ZYME) Analysts Are Reducing Their Forecasts For Next Year

Zymeworks Provides Corporate Update and Reports Third Quarter 2024 Financial Results
ZYME

GlobeNewswire

6 months ago

Zymeworks Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Zymeworks Inc (ZYME) Q3 2024 Earnings Report Preview: What To Look For
ZYME

GuruFocus.com

6 months ago

Zymeworks Inc (ZYME) Q3 2024 Earnings Report Preview: What To Look For

Zymeworks Announces Participation in Upcoming Investor Conferences
ZYME

GlobeNewswire

6 months ago

Zymeworks Announces Participation in Upcoming Investor Conferences

Zymeworks Presents New Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference
ZYME

GlobeNewswire

6 months ago

Zymeworks Presents New Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing Cancers
ZYME

GlobeNewswire

7 months ago

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing Cancers

Zymeworks to Report Third Quarter 2024 Financial Results and Host Conference Call on October 31, 2024
ZYME

GlobeNewswire

7 months ago

Zymeworks to Report Third Quarter 2024 Financial Results and Host Conference Call on October 31, 2024

Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference
ZYME

GlobeNewswire

8 months ago

Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference

Zymeworks Reports Inducement Grant Under Nasdaq Stock Market Rule 5635(c)
ZYME

GlobeNewswire

8 months ago

Zymeworks Reports Inducement Grant Under Nasdaq Stock Market Rule 5635(c)

Zymeworks Announces Participation in Upcoming Investor Conferences
ZYME

GlobeNewswire

9 months ago

Zymeworks Announces Participation in Upcoming Investor Conferences

News Flash: Analysts Just Made A Captivating Upgrade To Their Zymeworks Inc. (NASDAQ:ZYME) Forecasts
ZYME

Simply Wall St.

9 months ago

News Flash: Analysts Just Made A Captivating Upgrade To Their Zymeworks Inc. (NASDAQ:ZYME) Forecasts

Zymeworks Inc. (NASDAQ:ZYME) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
ZYME

Simply Wall St.

9 months ago

Zymeworks Inc. (NASDAQ:ZYME) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Zymeworks Second Quarter 2024 Earnings: Misses Expectations
ZYME

Simply Wall St.

9 months ago

Zymeworks Second Quarter 2024 Earnings: Misses Expectations

Zymeworks Announces Share Repurchase Program of up to $60 Million of its Common Stock
ZYME

GlobeNewswire

9 months ago

Zymeworks Announces Share Repurchase Program of up to $60 Million of its Common Stock

Zymeworks Provides Corporate Update and Reports Second Quarter 2024 Financial Results
ZYME

GlobeNewswire

9 months ago

Zymeworks Provides Corporate Update and Reports Second Quarter 2024 Financial Results

Zymeworks Announces Participation in Upcoming Investor Conferences
ZYME

GlobeNewswire

9 months ago

Zymeworks Announces Participation in Upcoming Investor Conferences

Zymeworks Appoints Leone Patterson as Chief Business and Financial Officer
ZYME

GlobeNewswire

9 months ago

Zymeworks Appoints Leone Patterson as Chief Business and Financial Officer

Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-⍺ Targeted Topoisomerase I Inhibitor Antibody-Drug Conjugate
ZYME

GlobeNewswire

10 months ago

Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-⍺ Targeted Topoisomerase I Inhibitor Antibody-Drug Conjugate

Zymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024
ZYME

GlobeNewswire

10 months ago

Zymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024

Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers
ZYME

GlobeNewswire

a year ago

Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers

Zymeworks (NASDAQ:ZYME) investors are sitting on a loss of 75% if they invested three years ago
ZYME

Simply Wall St.

a year ago

Zymeworks (NASDAQ:ZYME) investors are sitting on a loss of 75% if they invested three years ago

Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract Cancer
ZYME

GlobeNewswire

a year ago

Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract Cancer

Zymeworks Announces Participation in Upcoming Investor Conferences
ZYME

GlobeNewswire

a year ago

Zymeworks Announces Participation in Upcoming Investor Conferences

Zymeworks Inc. (NASDAQ:ZYME) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
ZYME

Simply Wall St.

a year ago

Zymeworks Inc. (NASDAQ:ZYME) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
ZYME

GlobeNewswire

a year ago

Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results

Zymeworks Announces Participation in Upcoming Investor Conferences
ZYME

GlobeNewswire

a year ago

Zymeworks Announces Participation in Upcoming Investor Conferences

We Think Zymeworks (NASDAQ:ZYME) Can Afford To Drive Business Growth
ZYME

Simply Wall St.

a year ago

We Think Zymeworks (NASDAQ:ZYME) Can Afford To Drive Business Growth

Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
ZYME

GlobeNewswire

a year ago

Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024

Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting
ZYME

GlobeNewswire

a year ago

Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting

Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
ZYME

GlobeNewswire

a year ago

Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors

Zymeworks Announces Participation in Upcoming Investor Conferences
ZYME

GlobeNewswire

a year ago

Zymeworks Announces Participation in Upcoming Investor Conferences

Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results
ZYME

GlobeNewswire

a year ago

Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results

Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting
ZYME

GlobeNewswire

a year ago

Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting

Zymeworks Announces Participation in Upcoming Investor Conferences
ZYME

GlobeNewswire

a year ago

Zymeworks Announces Participation in Upcoming Investor Conferences

Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call
ZYME

GlobeNewswire

a year ago

Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call

Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors
ZYME

GlobeNewswire

a year ago

Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors

ZYME

Business Wire

a year ago

Luminar To Provide Quarterly Business Update on February 27, 2024

Malibu Boats, Inc. Just Beat EPS By 24%: Here's What Analysts Think Will Happen Next
ZYME

Simply Wall St.

a year ago

Malibu Boats, Inc. Just Beat EPS By 24%: Here's What Analysts Think Will Happen Next

WEBINAR INVITATION | Okeanis Eco Tankers, Corp. (NYSE: ECO) (OSLO: OET) Live Investor Webinar on Friday, February 2, 2024 at 9:00 am ET
ZYME

GlobeNewswire

a year ago

WEBINAR INVITATION | Okeanis Eco Tankers, Corp. (NYSE: ECO) (OSLO: OET) Live Investor Webinar on Friday, February 2, 2024 at 9:00 am ET

Pick These 5 Bargain Stocks With Enticing EV-to-EBITDA Ratios
ZYME

Zacks

a year ago

Pick These 5 Bargain Stocks With Enticing EV-to-EBITDA Ratios

Zymeworks Announces Participation in Upcoming Investor Conferences
ZYME

GlobeNewswire

a year ago

Zymeworks Announces Participation in Upcoming Investor Conferences

Here's Why We Think Harmonic (NASDAQ:HLIT) Is Well Worth Watching
ZYME

Simply Wall St.

a year ago

Here's Why We Think Harmonic (NASDAQ:HLIT) Is Well Worth Watching

Trupanion Reconvenes Council on Animal Health to Provide Update on ‘Mystery’ Canine Respiratory Illness
ZYME

GlobeNewswire

a year ago

Trupanion Reconvenes Council on Animal Health to Provide Update on ‘Mystery’ Canine Respiratory Illness

Are Investors Undervaluing Costamare (CMRE) Right Now?
ZYME

Zacks

a year ago

Are Investors Undervaluing Costamare (CMRE) Right Now?

Investors Heavily Search Bank of America Corporation (BAC): Here is What You Need to Know
ZYME

Zacks

a year ago

Investors Heavily Search Bank of America Corporation (BAC): Here is What You Need to Know

Hope Bancorp Inc (HOPE) Reports Q4 and Full-Year 2023 Financial Results
ZYME

GuruFocus.com

a year ago

Hope Bancorp Inc (HOPE) Reports Q4 and Full-Year 2023 Financial Results

ZYME

Associated Press Finance

a year ago

Hope Bancorp: Q4 Earnings Snapshot

ZYME

Business Wire

a year ago

Hope Bancorp Declares Quarterly Cash Dividend of $0.14 Per Share

ZYME

Business Wire

a year ago

Hope Bancorp Reports 2023 Fourth Quarter and Full-Year Financial Results

IES Holdings Announces Fiscal 2024 First Quarter Results Earnings Release Schedule
ZYME

GlobeNewswire

a year ago

IES Holdings Announces Fiscal 2024 First Quarter Results Earnings Release Schedule

Unpacking Q3 Earnings: USANA (NYSE:USNA) In The Context Of Other Personal Care Stocks
ZYME

StockStory

a year ago

Unpacking Q3 Earnings: USANA (NYSE:USNA) In The Context Of Other Personal Care Stocks

BJ’s Restaurants, Dell, and More Stocks See Action From Activist Investors
ZYME

Barrons.com

a year ago

BJ’s Restaurants, Dell, and More Stocks See Action From Activist Investors

ZYME

Business Wire

a year ago

Tompkins Financial Corporation Reports Fourth Quarter Financial Results

ZYME

Business Wire

a year ago

Tompkins Financial Corporation Reports Cash Dividend

Hudson Pacific Properties Announces 2023 Dividend Tax Treatment
ZYME

Business Wire

a year ago

Hudson Pacific Properties Announces 2023 Dividend Tax Treatment

ZYME

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 01/25/2024

ZYME

Associated Press Finance

a year ago

Capitol Federal: Fiscal Q1 Earnings Snapshot

Capitol Federal Financial, Inc.® Reports First Quarter Fiscal Year 2024 Results
ZYME

Business Wire

a year ago

Capitol Federal Financial, Inc.® Reports First Quarter Fiscal Year 2024 Results

Carlyle Secured Lending, Inc. Schedules Fourth Quarter and Full Year 2023 Financial Results and Investor Conference Call
ZYME

GlobeNewswire

a year ago

Carlyle Secured Lending, Inc. Schedules Fourth Quarter and Full Year 2023 Financial Results and Investor Conference Call

Why Macy’s rejected its $5.8 billion buyout bid — and what’s next
ZYME

Yahoo Finance

a year ago

Why Macy’s rejected its $5.8 billion buyout bid — and what’s next

ANI Pharmaceuticals (ANIP) Beats Stock Market Upswing: What Investors Need to Know
ZYME

Zacks

a year ago

ANI Pharmaceuticals (ANIP) Beats Stock Market Upswing: What Investors Need to Know

Okeanis Eco Tankers Corp. – Commercial Update
ZYME

GlobeNewswire

a year ago

Okeanis Eco Tankers Corp. – Commercial Update

Forward Air to Close Acquisition of Omni Logistics
ZYME

PR Newswire

a year ago

Forward Air to Close Acquisition of Omni Logistics

ZYME

Associated Press Finance

a year ago

Northwest Bancshares: Q4 Earnings Snapshot

CorpAcq Reaffirms 2023 Guidance and Provides Business and Refinancing Update
ZYME

PR Newswire

a year ago

CorpAcq Reaffirms 2023 Guidance and Provides Business and Refinancing Update

Personal Care Stocks Q3 Recap: Benchmarking Herbalife (NYSE:HLF)
ZYME

StockStory

a year ago

Personal Care Stocks Q3 Recap: Benchmarking Herbalife (NYSE:HLF)

Freshpet, Tilly’s, and More Stocks See Action From Activist Investors
ZYME

Barrons.com

a year ago

Freshpet, Tilly’s, and More Stocks See Action From Activist Investors

ZYME

Business Wire

a year ago

Hope Bancorp to Report 2023 Fourth Quarter Financial Results on Tuesday, January 30, 2024

Viridian Therapeutics Announces Pricing of Public Offering of Shares of Common Stock
ZYME

Business Wire

a year ago

Viridian Therapeutics Announces Pricing of Public Offering of Shares of Common Stock

Blue Bird (BLBD) Receives Order of 180 e-Buses From LAUSD
ZYME

Zacks

a year ago

Blue Bird (BLBD) Receives Order of 180 e-Buses From LAUSD

Unpacking Q3 Earnings: Micron Technology (NASDAQ:MU) In The Context Of Other Semiconductors Stocks
ZYME

StockStory

a year ago

Unpacking Q3 Earnings: Micron Technology (NASDAQ:MU) In The Context Of Other Semiconductors Stocks

Definitive Healthcare Announces CEO Transition
ZYME

GlobeNewswire

a year ago

Definitive Healthcare Announces CEO Transition

IMAX Names Anne Globe as Chief Marketing Officer
ZYME

PR Newswire

a year ago

IMAX Names Anne Globe as Chief Marketing Officer

ZYME

Business Wire

a year ago

Ichor to Announce Fourth Quarter 2023 Financial Results on February 6th

Insider Selling Of REITs Picking Up: Is It Significant?
ZYME

Benzinga

a year ago

Insider Selling Of REITs Picking Up: Is It Significant?

Small Stocks, Massive Rewards: 3 Growth Picks with 1,000% Upside
ZYME

InvestorPlace

a year ago

Small Stocks, Massive Rewards: 3 Growth Picks with 1,000% Upside

LendingClub Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
ZYME

PR Newswire

a year ago

LendingClub Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

Share on Social Networks: